KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Non-Current Assets (2016 - 2025)

Novavax has reported Non-Current Assets over the past 16 years, most recently at $198.2 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $198.2 million for Q4 2025, down 54.06% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (down 45.42% YoY), and the annual figure for FY2025 was $198.2 million, down 54.06%.
  • Non-Current Assets for Q4 2025 was $198.2 million at Novavax, down from $205.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for NVAX hit a ceiling of $653.6 million in Q4 2023 and a floor of $198.2 million in Q4 2025.
  • Median Non-Current Assets over the past 5 years was $487.2 million (2022), compared with a mean of $478.4 million.
  • Biggest five-year swings in Non-Current Assets: surged 396.43% in 2021 and later plummeted 66.28% in 2025.
  • Novavax's Non-Current Assets stood at $421.6 million in 2021, then surged by 31.7% to $555.3 million in 2022, then increased by 17.71% to $653.6 million in 2023, then plummeted by 33.98% to $431.5 million in 2024, then crashed by 54.06% to $198.2 million in 2025.
  • The last three reported values for Non-Current Assets were $198.2 million (Q4 2025), $205.3 million (Q3 2025), and $417.0 million (Q2 2025) per Business Quant data.